KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medpace Holdings (MEDP) Debt to Equity (2016 - 2023)

Medpace Holdings (MEDP) has disclosed Debt to Equity for 7 consecutive years, with $0.14 as the latest value for Q2 2023.

  • For the quarter ending Q2 2023, Debt to Equity fell 92.02% year-over-year to $0.14, compared with a TTM value of $0.14 through Jun 2023, down 92.02%, and an annual FY2022 reading of $0.13, changed N/A over the prior year.
  • Debt to Equity was $0.14 for Q2 2023 at Medpace Holdings, down from $0.33 in the prior quarter.
  • Across five years, Debt to Equity topped out at $1.76 in Q2 2022 and bottomed at $0.09 in Q1 2019.
  • Average Debt to Equity over 3 years is $0.48, with a median of $0.24 recorded in 2023.
  • The sharpest move saw Debt to Equity tumbled 76.1% in 2019, then tumbled 92.02% in 2023.
  • Year by year, Debt to Equity stood at $0.09 in 2019, then skyrocketed by 44.27% to $0.13 in 2022, then increased by 8.69% to $0.14 in 2023.
  • Business Quant data shows Debt to Equity for MEDP at $0.14 in Q2 2023, $0.33 in Q1 2023, and $0.13 in Q4 2022.